Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Agarwal, S; Mader, JK; Arevalo, G; Avula, S; Chavez, E; Sloan, LA; Galindo, RJ.
Diabetes and Glucose Management in People on Hemodialysis.
Diabetes Spectr. 2025; 38(1): 7-18. Doi: 10.2337/dsi24-0015 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz

Mader Julia

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:

Diabetes is a major cause of end-stage kidney disease (ESKD). Glycemic management is challenging in this population, and A1C, commonly used for monitoring glycemic control, is unreliable. Continuous glucose monitoring indices can be used for glycemic monitoring in people with ESKD. Dipeptidyl peptidase 4 inhibitors, incretin mimetic agents (glucagon-like peptide 1 and glucose-dependent insulinotropic peptide receptor agonists), and insulin using an automated insulin delivery system are preferred to manage diabetes in people with ESKD on hemodialysis.

© Med Uni Graz • Imprint